China Pioneer Pharma Holdings Limited (1345.HK)

HKD 2.26

(1.35%)

Revenue Summary of China Pioneer Pharma Holdings Limited

  • China Pioneer Pharma Holdings Limited's latest annual revenue in 2023 was 1.56 Billion CNY , up 0.68% from previous year.
  • China Pioneer Pharma Holdings Limited's latest quarterly revenue in 2023 FY was 1.56 Billion CNY , up 0.68% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported a annual revenue of 1.55 Billion CNY in annual revenue 2022, up 8.45% from previous year.
  • China Pioneer Pharma Holdings Limited reported a annual revenue of 1.43 Billion CNY in annual revenue 2021, up 7.72% from previous year.
  • China Pioneer Pharma Holdings Limited reported a quarterly revenue of 1.56 Billion CNY for 2023 FY, up 0.68% from previous quarter.
  • China Pioneer Pharma Holdings Limited reported a quarterly revenue of 736.91 Million CNY for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of China Pioneer Pharma Holdings Limited (2023 - 2010)

Historical Annual Revenue of China Pioneer Pharma Holdings Limited (2023 - 2010)

Year Revenue Revenue Growth
2023 1.56 Billion CNY 0.68%
2022 1.55 Billion CNY 8.45%
2021 1.43 Billion CNY 7.72%
2020 1.33 Billion CNY 1.22%
2019 1.31 Billion CNY -18.98%
2018 1.62 Billion CNY -24.59%
2017 2.15 Billion CNY 20.31%
2016 1.79 Billion CNY 22.55%
2015 1.46 Billion CNY -5.16%
2014 1.54 Billion CNY 21.08%
2013 1.27 Billion CNY 32.7%
2012 958.72 Million CNY 33.56%
2011 717.83 Million CNY 25.79%
2010 570.64 Million CNY 0.0%

Peer Revenue Comparison of China Pioneer Pharma Holdings Limited

Name Revenue Revenue Difference
China Healthwise Holdings Limited 146.31 Million HKD -970.739%
Tycoon Group Holdings Limited 1.19 Billion HKD -30.703%
Beijing Tong Ren Tang Chinese Medicine Company Limited 1.52 Billion HKD -2.736%